Todd Branning
Chief Executive Officer at NEUBASE THERAPEUTICS, INC.
Net worth: 1 012 $ as of 2024-04-29
Profile
Todd P.
Branning's career history includes current positions as Director at Amneal Pharma UK Holdings Ltd., Director at Amneal UK Holding Co. Ltd., and Chief Executive & Financial Officer & Secretary at NeuBase Therapeutics, Inc. Former positions include Chief Financial Officer & Senior Vice President at Teva Pharmaceuticals USA, Inc., Vice President-Finance at Allergan Ltd.
(Ireland), Chief Financial Officer & Senior Vice President at Amneal Intermediate, Inc., and Chief Financial Officer & Treasurer at Phathom Pharmaceuticals, Inc. Mr. Branning holds an MBA from Carnegie Mellon University and an undergraduate degree from the University of Miami.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
NEUBASE THERAPEUTICS INC
0.06% | 2024-03-27 | 2,290 ( 0.06% ) | 1 012 $ | 2024-04-29 |
Todd Branning active positions
Companies | Position | Start |
---|---|---|
NEUBASE THERAPEUTICS, INC. | Chief Executive Officer | 2024-01-15 |
Amneal Pharma UK Holdings Ltd.
Amneal Pharma UK Holdings Ltd. Medical DistributorsDistribution Services Part of Amneal Pharmaceuticals, Inc., Amneal Pharma UK Holdings Ltd. is a company that sells pharmaceutical products. Amneal Pharma UK Holdings Ltd. is based in Felsted, UK. Founded in 2013. | Director/Board Member | 2019-04-16 |
Amneal UK Holding Co. Ltd.
Amneal UK Holding Co. Ltd. Financial ConglomeratesFinance Part of Amneal Pharmaceuticals, Inc., Amneal UK Holding Co. Ltd. is a company that functions as an investment holding company. Amneal UK Holding Co. Ltd. is based in London, UK. Founded in 2017. | Director/Board Member | 2019-04-16 |
Former positions of Todd Branning
Companies | Position | End |
---|---|---|
PHATHOM PHARMACEUTICALS, INC. | Director of Finance/CFO | 2021-06-03 |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Director of Finance/CFO | 2020-03-10 |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Director of Finance/CFO | 2017-12-31 |
ALLERGAN PLC | Corporate Officer/Principal | 2016-07-31 |
Training of Todd Branning
Carnegie Mellon University | Masters Business Admin |
University of Miami | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
PHATHOM PHARMACEUTICALS, INC. | Health Technology |
Private companies | 6 |
---|---|
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Health Technology |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Health Technology |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Amneal Pharma UK Holdings Ltd.
Amneal Pharma UK Holdings Ltd. Medical DistributorsDistribution Services Part of Amneal Pharmaceuticals, Inc., Amneal Pharma UK Holdings Ltd. is a company that sells pharmaceutical products. Amneal Pharma UK Holdings Ltd. is based in Felsted, UK. Founded in 2013. | Distribution Services |
Amneal UK Holding Co. Ltd.
Amneal UK Holding Co. Ltd. Financial ConglomeratesFinance Part of Amneal Pharmaceuticals, Inc., Amneal UK Holding Co. Ltd. is a company that functions as an investment holding company. Amneal UK Holding Co. Ltd. is based in London, UK. Founded in 2017. | Finance |
NeuBase Therapeutics, Inc.
NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on August 4, 2009 and is headquartered in Pittsburgh, PA. | Health Technology |
- Stock Market
- Insiders
- Todd Branning